|
|
|
Volumn 13, Issue 3, 2005, Pages 90-95
|
|
Will pharmacogenomic discoveries improve HIV therapeutics?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2',3' DIDEOXYNUCLEOSIDE DERIVATIVE;
ABACAVIR;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIRETROVIRUS AGENT;
NEVIRAPINE;
ARTICLE;
GENETIC POLYMORPHISM;
GENETICS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MAJOR HISTOCOMPATIBILITY COMPLEX;
PHARMACOGENETICS;
ANTI-HIV AGENTS;
ANTI-RETROVIRAL AGENTS;
DIDEOXYNUCLEOSIDES;
HIV INFECTIONS;
HUMANS;
MAJOR HISTOCOMPATIBILITY COMPLEX;
NEVIRAPINE;
PHARMACOGENETICS;
POLYMORPHISM, GENETIC;
|
|
EID: 32944468048
PISSN: 15428826
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (17)
|
|
References (0)
|
